Readystate Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$737K Buy
+1,500
New +$814K 0.03% 422
2025
Q2
Sell
-5,400
Closed -$2.69M 919
2025
Q1
$2.69M Buy
5,400
+1,900
+54% +$1.03M 0.09% 281
2024
Q4
$1.82M Sell
3,500
-9,700
-73% -$5.33M 0.06% 330
2024
Q3
$8.17M Buy
13,200
+12,000
+1,000% +$7.1M 0.15% 260
2024
Q2
$664K Sell
1,200
-25,700
-96% -$14.7M 0.02% 435
2024
Q1
$15.6M Buy
26,900
+26,500
+6,625% +$14.9M 0.22% 84
2023
Q4
$212K Buy
+400
New +$194K 0.01% 526

Other funds holding TMO

Readystate Asset Management's TMO Position: Q2 2025 in Review

Readystate Asset Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 691 shares — an estimated $344K sold.

Readystate Asset Management first reported a position in TMO in Q3 2024 and held it in 3 quarters. The position peaked at $1.15M in Q4 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Readystate Asset Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 691 Thermo Fisher Scientific shares in Q2 2025, an estimated $344K.
  • Readystate Asset Management first reported a position in Thermo Fisher Scientific in Q3 2024 and held it in 3 quarters.
  • Readystate Asset Management's Thermo Fisher Scientific position peaked at $1.15M in Q4 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.